The synthetic triterpenoid RTA 405 (CDDO-EA) halts progression of liver fibrosis and reduces hepatocellular carcinoma size resulting in increased survival in an experimental model of chronic liver injury - Getachew, Y; Cusimano, F A; Gopal, P; Reisman, S A; Shay, J W (Toxicol Sci, 2016)